Cargando…
A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial
OBJECTIVES: The aim of the study was to demonstrate the non-inferiority of a single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate (SH) vs 0.8% hylan G-F 20 (control) in symptomatic knee osteoarthritis. DESIGN: This was a double-blind, randomized, controlled trial condu...
Autores principales: | Maheu, Emmanuel, Avouac, Bernard, Dreiser, Renée Liliane, Bardin, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903764/ https://www.ncbi.nlm.nih.gov/pubmed/31821355 http://dx.doi.org/10.1371/journal.pone.0226007 |
Ejemplares similares
-
Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action
por: Moreland, Larry W
Publicado: (2003) -
Non-Inferiority of a Single Injection of Sodium Hyaluronate Plus Sorbitol to Hylan G-F20: A 6-Month Randomized Controlled Trial
por: Cortet, Bernard, et al.
Publicado: (2021) -
Hylan GF-20 Viscosupplementation in the Treatment of Symptomatic Osteoarthritis of the Knee: Clinical Effect Survivorship at 5 Years
por: Boutefnouchet, Tarek, et al.
Publicado: (2017) -
Predictors of successful treatment in patients receiving intra-articular injections of hylan G-F 20 or saline for painful first MTPJ OA
por: Munteanu, Shannon, et al.
Publicado: (2011) -
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
por: Chevalier, X, et al.
Publicado: (2009)